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Abstract
A new optical fiber and method of manufacturing the same developed for use with surgical laser systems. The
fiber core utilizes an ultra-low expansion (ULE) material. The preferred ULE fiber consists of silicon dioxide
core doped with titanium dioxide which is cladded and jacketed for chemical and abrasion resistance. The
resulting fiber is stable against degradation due to thermal expansion.
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METHODS FOR LASER TREATMENT OF 
TISSUE 
RELATED APPLICATIONS 
This is a division of application Ser. No. 08/209,002, ?led 
Mar. 10, 1994, Which is a continuation-in-part of application 
Ser. No. 07/950,913, ?led Sep. 24, 1992 (noW abandoned). 
STATEMENT REGARDING GOVERNMENT 
RIGHTS 
The present invention Was made With government support 
from the US. Department of Commerce under Grant No. 
ITA 87-02. The Government may have certain rights in this 
invention. 
FIELD OF THE INVENTION 
The present invention relates to the ?eld of laser ?bers. 
More particularly, the present invention relates to laser ?bers 
constructed of ultra-loW-expansion (ULE) materials and 
methods of making such ?bers. 
BACKGROUND OF THE INVENTION 
(Throughout this Speci?cation, there appear numbered 
superscripts. These refer to prior art references listed by 
number in the “Other Documents” portion of the “Informa 
tion Disclosure Statement” that accompanied the parent 
application identi?ed above.) 
For many years, lasers have been used for a variety of 
surgical procedures. The desired effects may be thermal, 
photodisruptive or photo-chemical. Lasers may be delivered 
to and targeted on the treatment site by either a free beam 
system using mirrors or by directing the laser light in an 
optical ?ber. Optical ?bers have been the preferred system 
of laser delivery for surgical procedures, if the desired 
Wavelength can be transmitted through the ?ber. In a non 
contact mode, the optical ?ber has no effect on the Wave 
length speci?c tissue effect. 
Most lasers currently used for medical-surgical proce 
dures are used for their thermal effect Which is dependent 
upon the speci?c Way the laser light energy is transferred to 
thermal energy in the tissue. A common laser used is the 
carbon dioxide (CO2) laser Whose Wavelength at 10.6 pm 
makes it opaque to cellular Water. The CO2 laser is therefore 
totally absorbed by Water and rapidly converted to thermal 
energy over a very short distance (<100 pm). 
Recently, Nd:YAG laser systems, coupled to silica ?bers 
With either sculptured or bare tips or With sculptured sap 
phire tips, have shoWn great bene?ts as surgical tools When 
used for certain procedures.1’6 Using these laser systems 
With a bare ?ber, photocoagulation to tissue depths of 4 to 
5 mm in tissue can be attained in a non-contact mode.6712 In 
a contact mode, incision and cauteriZation of the nearby 
tissue can be aCh16V6d.13T2O 
These tWo capabilities, though providing the surgeon With 
neW and poWerful tools in performing procedures that are 
very close to being hemostatic, have as yet to be integrated 
into a full spectrum of laser optical ?ber surgical systems. At 
one extreme, only photocoagulation can be achieved in a 
non-contact mode While at the other extreme only incision 
can be achieved in a contact mode. BetWeen these tWo 
extremes, there is a range of combined and controlled 
photocoagulation and incision that Would be highly 
desirable, and a ?ber optic system that could provide this 
full-spectrum capability Would provide the surgeon With a 
broad range of neW surgical capabilities to meet the speci?c 
needs of a broad range of surgical procedures. 
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The most common optical ?ber material used for the 
delivery of laser light energy at the present time is silica 
glass. Indeed, the same glass chemistry presently used in all 
optical ?bers for laser surgery is also used in telecommu 
nication optical ?bers. These optical ?ber cables are capable 
of transmitting laser light through very small diameters and 
they can be threaded to almost any part of the body creating 
little or no damage to surrounding normal tissue. These ?ber 
optic delivery systems are, therefore, ideal for use With 
endoscopy. 
Such silica ?bers have been shoWn to be highly effective 
in photocoagulating tissue in a non-contact mode. HoWever, 
When these ?bers come into contact With tissue or blood 
there is signi?cant thermal-mechanical damage to the ?ber 
and disruption of light transmission. This disruption limits 
the focusing of the laser and causes the laser energy incident 
upon the damaged optical ?ber tip to be converted into 
thermal heating of the tip. Hence, after the degradation of the 
optical ?ber tip has begun, the ?ber can no longer be used 
for photocoagulation. 
When the ?ber optic cable contacts tissue, there is a 
marked change in the tissue response and a signi?cant 
reduction in the tissue transmission of the laser light. 
Because of the absorption of laser energy at the optical ?ber 
tip at the tissue contact surface, the ?ber is rapidly heated to 
high temperatures thereby destroying the optical quartZ 
?ber. The effect on the surrounding tissue is variable and has 
an unpredictable tissue damage pattern. 
The thermal-mechanical breakdoWn of the optical ?ber 
that folloWs the use of the ?ber in a contact mode also results 
in the contamination of the incisional site With silica glass 
fragments. These fragments may present a bio-haZard as 
their effect on tissue has not been fully studied. Perhaps 
more importantly, the use of a technique for precise laparo 
scopic dissection that creates a variable tissue effect With 
signi?cant lateral coagulation is less than optimal. 
Sapphire tips have been used in an attempt to incise tissue 
Without destruction of the optical ?ber. Examples of this 
approach are found in DaikuZono US. Pat. No. 4,693,244 
and Hoshino US. Pat. No. 4,832,979. 
Sculptured sapphire tips range in shapes from long small 
angle cones, to shorter sharper-angle cones, to blunt end 
cylinders to rounded semi-spheres. It is believed that by 
changing the angle at the end of the sapphire tip, the 
focusing or defocusing of the laser light can be achieved; 
small, sharp angles tending to focus the light doWn to 
smaller angles Whereas larger angles, such as the rounded 
semi-sphere ends, tending to defocus the laser light. The 
belief is that by changing this angle, the nature of the tissue 
response can be changed from incision at the highly focused 
extreme to photocoagulation at the defocused extreme. 
Although this effect of focusing and defocusing may be 
the case When the optical ?ber is used in non-contact, it is 
likely not the case When used in the contact mode. Rather it 
is our experience that With the sapphire tips, the energy 
transmission from the ?ber to the tissue is dominated by the 
contact surface betWeen the tissue and the sapphire tip. As 
With the optical ?ber, for a short time, the sapphire tip Will 
lase in contact With the tissue but then it breaks doWn and the 
tip Will only incise the tissue in a manner similar to that of 
the silica ?ber tip. The sapphire tip, hoWever, due to its 
single crystal structure, When heated by the laser fails 
catastrophically along Well-de?ned crystallographic planes. 
Hence, rather than small pieces or ?akes of the sapphire tip 
coming off the tip in a gradual manner as is the case With the 
silica optical ?ber, the sapphire tip cracks along the entire 
5,829,445 
3 
length of the tip and large chunks of the tip fall off into the 
surrounding tissue area. Such failure is catastrophic in the 
sense that these larger pieces of sapphire (typically 1—2 
mm><1—2 mm) are quite hot due to the laser heating and 
When they contact the tissue, they cause thermal damage to 
surrounding normal tissue in the surgical area and must be 
retrieved from the site. 
Another failure mechanism of ?bers With sapphire tips is 
that because they are composite systems, the sapphire tip 
must be connected to the optical ?ber cable. The most 
common method of attachment includes a small brass ferrule 
compression ?tted onto the te?on protective jacket of the 
?ber. Because the sapphire is a good thermal conductor, the 
brass ferrule is heated along With the sapphire tip and, in 
some instances of continued use, melts the te?on jacket and 
falls off into the surgical area. In this case, both the sapphire 
tip and the brass ferrule can burn the tissue at the surgical 
site. As a result, both the sapphire tip and brass ferrule must 
be retrieved from the surgery site before the damage to the 
tissue is extensive. Hence, as With the silica ?bers, the 
sapphire tips degrade and contaminate the surgery tissue site 
When used in a contact mode. 
Other attempts at providing ?bers for contact laser sur 
gery have been directed to coating the ?ber tip With infrared 
absorbing material, as taught in DaikuZono US. Pat. No. 
4,736,743, or, in a manner similar to that used in sapphire 
contact tips, changing the tip con?guration to modify the 
laser beam and reduce localiZed heating at the tip. These 
attempts have not met With success because, even though 
they are speci?cally designed for contact applications, they 
suffer from the same thermal expansion and eventual deg 
radation described above for the silica ?ber tips and sapphire 
tipped ?bers. 
The use of laser energy in the blue-green region of the 
electromagnetic spectrum to incise tissue provides advan 
tages in tissue With a high hemoglobin concentration 
(usually indicated in tissue With high degrees of vascularity 
such as the liver). The absorption of such energy is increased 
by the high iron content of such regions. These systems also 
use simple and inexpensive silica optical ?ber delivery 
system. One important disadvantage is that these systems 
are typically used only in non-contact procedures. 
Presumably, these silica-based laser systems Would suffer 
the same thermal-mechanical break doWn as do the Nd:YAG 
laser ?ber systems if used in contact procedures. 
Although some of the ?bers described above can provide 
adequate performance When used in non-contact applica 
tions to accomplish photocoagulation, the reality facing 
surgeons is that contact betWeen the ?ber tips and tissue is 
extremely dif?cult to avoid due to the close quarters in 
Which these devices operate. Once the ?ber or sapphire tip 
contacts tissue and degradation of the tip surface occurs. 
After the initial degradation occurs, the performance (for 
either photocoagulation or incision) of the ?ber can no 
longer be accurately predicted by the surgeon. If predictable 
characteristics are required, a neW ?ber tip must be created, 
either by cutting and polishing a neW tip (a laborious, time 
consuming process) or by replacing the entire ?ber. Both of 
these options increase the cost of the laser surgery. 
In summary, the laser optical ?ber systems currently in 
use, silica or otherWise, remain useful as photocoagulating 
or incisional tools only so long as they are used in non 
contact procedures. Given the close nature of the environ 
ments in Which these devices operate, hoWever, contact and 
the resulting degradation are dif?cult, if not impossible, to 
avoid. As such, there is a need for a ?ber material which 
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provides predictable operating characteristics in either a 
contact or non-contact mode and Which can be modi?ed to 
provide a predictable balance betWeen photocoagulation and 
contact incision. 
SUMMARY OF THE INVENTION 
The present invention provides a ?ber optic cable With a 
core formed of ULE materials Which exhibits predictable 
characteristics regardless of its use in methods involving 
non-contact, contact or a combination of both. As a result, 
?bers according to the present invention are useful for 
photocoagulation, incision (contact or non-contact) or a 
combination of photocoagulation and incision. 
Because of the extremely loW expansion coef?cients of 
the ULE materials, ?bers according to the present invention 
retain their integrity and, as a result, their characteristics 
such as energy transmission/absorbance far longer than 
?bers constructed of conventional materials. 
Furthermore, because the ULE material does not degrade 
rapidly When heated, it can be intentionally processed to 
absorb a predetermined percentage of laser energy at the tip, 
thus providing a useful thermal incision device, in addition 
to providing a consistent, predetermined percentage of laser 
energy for photocoagulation. The energy absorption is pref 
erably accomplished by doping the ?ber tip With an absorb 
ing specie, such as a colored transition metal ion Which 
provides a desired level of energy absorption. That prede 
termined level of energy absorbance can be used to control 
the extent of the input laser energy that is used to incise 
tissue. If no dopant Were added to the tip, then substantially 
all of the laser energy incident on the tip Would be trans 
mitted to the tissue and complete photocoagulation Would 
result. If the tip Were doped With a laser absorbing specie 
then a fraction of laser energy Would be absorbed at the ?ber 
contact tip and the tip Would be heated to a temperature that 
Would be proportional to the level of doping in the tip. 
Lightly doped tips Will incise tissue lightly and heavily 
doped tips Will incise tissue heavily. In the extreme of 
doping, substantially all of the laser energy Would be 
absorbed at the ?ber tip and the result Would be a 100% 
incisional ?ber tip. 
Although fully incisional ?ber tips already exist (i.e., 
those ?bers Which have suffered thermal-mechanical break 
doWn either by using tissue or the commonly used practice 
of degrading the ?ber With a Wooden tongue blade), the 
bene?t With the ?ber system of the invention is that a fully 
incisional ?ber Would be but one of a ?ll spectrum of such 
?bers Where the extent of photocoagulation or incision is 
predetermined. Furthermore, the silica ?bers in common use 
must be intentionally damaged to yield this performance and 
this damage continues so long as the ?bers are used, leaving 
behind a small but measurable residue of glass fragments in 
and along the tissue incisional site. 
In one aspect of the invention, the laser optical ?ber 
comprises ultra-loW expansion (ULE) materials, coated With 
a Waveguiding cladding material, typically a UV-curable 
silicone acrylate polymer, jacketed With a protective 
polymer, typically te?on, and used With a laser, typically a 
Nd:YAG laser. Such optical ?bers exhibit near Zero thermal 
shock over a Wide range of temperatures and as a result 
remain stable When used in contact With tissue and energiZed 
With a laser. 
ULE ?bers according to the present invention can also be 
doped or otherWise modi?ed to provide a range of controlled 
photocoagulation and/or incision of tissue depending upon, 
for example, the extent of doping With a laser absorbing 
specie, typically a transition metal ion, like Fe+2 or Fe+3. 
5,829,445 
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These and various other advantages and features Which 
characterize the invention are pointed out With particularity 
in the attached claims. For a better understanding of the 
invention and its advantages, reference should be made to 
the draWings Which form a part hereof, and to the accom 
panying description, in Which various preferred and alter 
nate embodiments and methods according to the present 
invention are described in more detail. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a chart shoWing the percent of linear expansion 
versus temperature of four different bulk material and ?ber 
specimens; 
FIG. 2 is a chart shoWing the fractional linear expansion 
versus temperature for a series of titania (TiO2) doped silica 
(SiO2) ?bers; 
FIG. 3 is a chart shoWing the average expansion 
coef?cients, de?ned as the rate of change of the linear 
expansion With temperature, for three ranges of 
temperatures, for titania doped silica ?bers of different 
Weight percentages; and 
FIG. 4 depicts the relative relationship betWeen ?bers 
according to the present invention and knoWn silica glass 
?bers When compared on a poWer vs. time graph indicating 
stable Working regions. 
FIG. 5 is a chart shoWing the range of performance of an 
optical ?ber utiliZing the principles of the invention. 
DESCRIPTION OF THE PREFERRED AND 
ALTERNATE EMBODIMENTS OF THE 
INVENTION 
According to the principles of the invention, the problem 
of the optical ?ber thermal-mechanically degrading When in 
contact With tissue is controlled by increasing the thermal 
shock resistance of the optical ?ber. To accomplish this, 
ULE material ?bers are used Which, When coated With a hard 
polymer cladding and jacketed With a tough te?on abrasion 
and chemical resistant layer, provide a surgical optical ?ber 
that is resistant to thermal shock-induced failure. 
Typically, knoWn silica ?ber core materials exhibit ther 
mal coef?cients of linear expansion of 0.5><10_6/°C. or 
greater for Working temperatures of 25° to 700° C. Preferred 
ULE materials according to the present invention, hoWever, 
exhibit thermal coef?cients of linear expansion of less than 
about 0.5><10_6/°C. in the same temperature range. The exact 
coef?cients of the ULE materials are, of course, dependent 
on temperature and the nature of the ULE material being 
used. At all temperatures, hoWever, ULE materials accord 
ing to the present invention Will exhibit linear thermal 
coef?cients of expansion less than that of silica glass. 
The preferred ULE material according to the present 
invention comprises titania-doped silica glass, variations of 
Which are described in greater detail beloW. Other ULE 
materials include, but are not limited to, ?bers made of a 
glass-ceramic containing Li2O, A1203, and SiO2. 
FIGS. 1 and 2 shoW that silica ?bers exhibit substantially 
larger thermal expansion coef?cients than titania-doped 
ULE silica glasses. FIG. 1 is a chart illustrating the linear 
expansion of four different bulk glasses and ?bers at various 
temperatures: a silica (quartz) glass rod, a section of a 
commercial 600 pm silica optical ?ber, a titania-doped silica 
ULE glass rod and a section of ULE ~600 pm optical ?ber. 
FIG. 1 shoWs that the ULE glass exhibits a much less 
expansion than that of the commercial silica. FIG. 1 also 
shoWs that the ULE glass exhibits the ULE behavior even in 
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the ?ber form. Because thermal stresses across a given ?ber 
generated by a temperature gradient are inversely propor 
tional to the expansion coef?cient of the material used to 
form the ?ber, it is expected that such ULE ?bers Would be 
much less susceptible to thermal stress failure and as a result 
tend to remain stable When the ?ber is brought into contact 
With tissue and energiZed With a laser. 
FIG. 2 shoWs that the thermal expansion of the titania 
doped glass decreases substantially as the titania dopant 
concentration increases from 0 to about 6—8% (Weight). FIG. 
2 also shoWs that the titania doping dramatically decreases 
the linear expansion to the extent that by 6 to 7.5 Wt % TiO2, 
the expansion coef?cient is near Zero for a Wide range of 
temperatures, up to ~800° C. The slope of each curve shoWn 
on FIG. 2 is de?ned as the expansion coef?cient, Which 
determines the thermal shock resistance of the ?ber. 
These slopes are shoWn on FIG. 3 for three ranges of 
temperatures, +5° to +35° C., +25° to +700° C., and —200° 
to +5° C. In the present application, the range of +25° to 
+700° C. is applicable. FIG. 3 shoWs that for this range the 
average expansion coef?cient reaches Zero (in?nite thermal 
shock resistance) near a doping of 7.5 Wt % TiO2. Thus, a 
glass With this doping Would have a thermal shock resistance 
approaching in?nity. Although in practice such values Would 
never be attained, the thermal shock resistance Would 
increase dramatically for glass With a titania-doping level 
near 7.5 Wt % 
FIG. 4 is a graphic representation of the relative stable 
Working regions (as a function of laser poWer versus time) 
of both ?bers according to the present invention and knoWn 
?bers. The Working regions of ?bers according to the present 
invention, represented by the area under line 10, provide an 
increased stable Working envelope When compared to the 
area under line 12, Which represents the stable Working 
region of knoWn ?bers. As shoWn in FIG. 4, ULE ?bers can 
be used for longer periods of time and/or at higher poWer 
levels (relative to silica glass ?bers) Without degradation 
suf?cient to substantially affect the performance of the 
?bers. 
It should be noted that FIG. 4 depicts the relationship 
betWeen lines 10 and 12 in a relative, as opposed to absolute 
sense. The actual relationship Will depend on the character 
istics of the tissue in contact With the ?bers and other factors. 
In all cases, hoWever, the stable Working limits of ULE ?bers 
according to the present invention Will exceed those of 
knoWn silica ?bers. 
Because of the stable nature of ULE ?bers according to 
the present invention, they may be intentionally provided in 
embodiments Which absorb a desired, predetermined 
amount of laser energy Which is then converted to heat for 
incision or other purposes. KnoWn silica ?bers Would 
degrade under such conditions, but the loW linear thermal 
coef?cients of expansion of ULE materials used in ?bers 
according to the present invention, provide a larger range of 
thermal stability. Techniques of modifying the ?bers to 
include a means for heating the ?ber tip through the absorp 
tion of laser energy include, but are not limited to, abrading 
the ?ber tip or doping the tip With a laser absorbing specie. 
The preferred method of modifying the ULE ?bers to 
increase energy absorption and decrease transmission of 
laser energy is doping the ?ber tips. The ?ber tips can be 
doped to varying extents With a laser absorbing specie to 
provide for controlled photocoagulation and/or incision of 
tissue depending upon the extent of doping of the ?ber tip. 
Fibers Which are more heavily doped Will absorb more laser 
energy, converting it into thermal energy at the tip of the 
5,829,445 
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?ber. Fibers Which are lightly doped, or not doped at all, Will 
absorb less laser energy, thereby passing more energy out of 
the ?ber to provide increased photocoagulation. 
Preferably, the laser absorbing specie is a transition metal 
ion like Fe+2 or Fe+3. Other laser absorbing specie can be 
used in place of the preferred specie. Examples include, but 
are not limited to: Co”, Mn+2 and Ni”. 
The preferred method of doping the tip With the laser 
absorbing specie is to coat the area to be doped, typically the 
distal end tip, With a solution or slurry containing the dopant. 
The tip and solution are then heated to about 1000° C. in a 
small electric furnace. By holding the coated tip at this 
temperature for a period of time, preferably a feW minutes 
to less than an hour, the dopant Will dissolve into the tip 
causing a homogenous concentration throughout the tip 
volume. The concentration in the tip is governed by the 
amount and concentration of dopant placed on the surface of 
the tip prior to heating. 
Alternate methods of doping the ULE ?bers according to 
the present invention Will be knoWn to those skilled in the 
art, including, but not limited to ion implantation, etc. 
FIG. 5 illustrates the range of the performance of various 
optical ?bers produced according to the principles of the 
invention, Which may be used in contact With tissue. At the 
far left, FIG. 5 depicts the performance of a ?ber tip that has 
no laser absorbing dopant and, as a result, the ?ber transmits 
100% of the laser energy into the tissue medium. At the far 
right, FIG. 5 depicts the performance of a ?ber tip doped 
With the maximum amount of the laser absorbing dopant and 
as a result, the ?ber converts 100% of the laser energy into 
heat at the ?ber tip. 
BetWeen the tWo extremes depicted in FIG. 5, a range of 
dopant concentrations exist Where a fraction of the laser 
energy is converted to heat at the tip and the remaining 
fraction of laser energy is transmitted through the ?ber tip to 
the time. This characteristic enables the production of a 
range of different laser optical ?bers Which can be used to 
provide a predetermined amount of both photocoagulation 
and incision depending upon the amount of doping. 
In addition to being able to Withstand the natural thermal 
cycling that results from energiZing these optical ?bers in 
contact With tissue, ULE optical ?bers also have the unique 
ability to Withstand the thermal cycling arising from high 
peak energy levels in use With rapidly pulsed “Q-sWitched” 
laser systems. Whether thermal cycling arises from the 
tissue contact or from internal heating due to a pulsed laser 
or a combination of the tWo or other phenomena, the near 
Zero expansion of the ULE optical ?bers makes them 
uniquely suited for such applications, especially neW appli 
cations such as photo-disruptive laser therapy and/or sur 
gery. 
Such titania-doped silica ?bers also are non-toxic, straight 
forWard and inexpensive to prepare, chemically inert, and 
are optically transparent from the ultraviolet to the infrared. 
For these reasons, ULE optical ?bers can be produced and 
?beriZed into contact tips for use With all standard laser 
optical ?ber delivery systems. Such ?bers Would be com 
patible With all medical laser optical ?ber delivery systems 
using visible and near-infrared laser energy. The diameters 
of such ?bers typically range from 100 to 1000 pm, With the 
most common being 600 pm. These diameters are the most 
commonly used diameters in practice today. The optical 
connectors for the tips are standard “SMA” connectors 
commonly used in laser systems. The ?bers can be attached 
into ?ber handholding devices in a fashion commonly in use 
today. In short, all of the knoWn uses, optical connectors, 
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laser delivery systems and packaging methods are com 
pletely compatible With the ULE optical ?bers of the inven 
tion. In fact, this compatibility is a tremendous advantage. 
As is standard in the art and practice and knoWn to those 
skilled in the art, ?bers produced using the principles of the 
invention are clad With a hard polymer and jacketed With a 
tough buffer material, typically te?on or tefZel. The pre 
ferred cladding is a ?uoracrylate material, although other 
cladding materials can also be used, including, but not 
limited to silicone acrylate polymers and other materials. 
The distal ends of the ?bers can be formed into any of a 
range of different con?gurations. All such con?gurations 
and others commonly used are suitable for use With the ULE 
optical ?bers of the invention When used either in a contact 
or non-contact mode. 
All con?gurations of the ULE laser optical ?bers of the 
invention are compatible With NdzYAG, argon-ion, KTP or 
any other laser system operating betWeen the Wavelengths of 
@200 nm to 3000 nm. The preferred ULE laser optical ?bers 
of the invention are compatible With these lasers producing 
up to @120 Watts for a ?ber diameter of 600 pm. 
Although the neW ULE laser optical ?ber of the invention 
has been developed to be 100% compatible in every Way to 
the pure silica laser optical ?ber, it has been found that 
differences do exist in the Way in Which the ULE optical 
?bers are prepared. 
In a typical preparation of silica optical ?bers, a prepol 
ished pure silica ?ber preform glass rod is chucked into a 
preform holder, inserted into a graphite element argon gas 
environment furnace, heated up to the ?ber draWing 
temperature, and then pulled into ?ber form at a precisely 
controlled speed and temperature. The pulled ?ber is then 
immediately coated With a hard acrylic protective and Wave 
guiding cladding, tension tested for minimum strength and 
then Wound onto a take up spool. Such ?ber draWing 
practices have been developed over some time, and the ULE 
?ber draWings is compatible With all of these practices 
except that the ?ber is preferably pulled using an air or 
oxygen atmosphere furnace. 
The air or oxygen atmosphere is required to keep the 
titanium in the doped preform in its highest (Ti+4) oxidation 
state. If the glass preform is reduced (Ti+4—>Ti+3) then this 
reduces the ?bers’ ability to transmit the laser light because 
of the blue coloring indicative of the Ti+3 in the ?bers. Such 
?bers cannot be used as surgical tools because they Will not 
transmit laser energy. 
It has been our ?nding that the commercially available 
ULE titania-doped silica glass contains reduced titania (Ti+ 
3) such that When core-drilled preforms of this glass are 
pulled, even in oxidiZing atmospheres, the ?bers are 
severely colored blue and Will not transmit laser energy. This 
problem makes commercially available ULE glass preforms 
unusable for ?beriZing laser optical ?bers. 
For this reason, the glass preform must be processed to the 
proper Ti+4 oxidation state before it is pulled into a ?ber 
useable for transmission of laser energy according to the 
present invention. In one preferred method, annealing the 
glass preform in air at 1000° C. for periods ranging from 18 
to 24 hours, the glass preforms Will oxidiZe to the Ti+4 state 
such that When the ?bers are pulled from these annealed 
preforms they are colorless and Will transmit laser light. In 
an alternate preferred method, the preforms may be annealed 
for 48—72 hours in an oxygen atmosphere at temperatures of 
1000° to 1200° C. before pulling. ULE ?bers pulled from 
preforms treated according to the present invention transmit 
substantially all of the laser energy directed through them. 
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Apparently, the Ti+3 in the commercially available titania 
doped ULE material arises from the manufacturing process, 
and therefore changes in the process could result in preforms 
already in the oxidized state. Currently, chemical vapor 
deposition (CVD) techniques are used to prepare the glass 
preforms. One such CVD technique is taught in Us. Pat. 
No. 2,326,059. These prior art processes do not take special 
precautions to insure the correct oxidiZation state of the 
titanium in the glass and, as a result, typically could not be 
used to manufacture useable laser ?bers. Special precautions 
are taken only to insure that the titanium is delivered to the 
reaction chamber in high purity and in the correct stoichi 
ometry. It is believed that the glass preforms produced by 
knoWn CVD techniques result in substantial amounts of 
reduced titania, i.e., Ti+3. Therefore, to produce glass pre 
forms that can be pulled into ?bers suitable for transmission 
of laser energy, special care must be taken to insure not only 
high purity and correct stoichiometry, but the correct oxi 
dation state of the titanium as Well. 
In the methods according to the present invention, pure 
oxygen is used in the CVD reaction chamber resulting in the 
oxidation of the TiCl4 and SiCl4 gas streams to TiO2 and 
SiO2, respectively, thus maintaining suitable levels of Ti+3 
and Ti+4 in the ULE ?bers suf?cient to alloW the transmis 
sion of substantially all laser energy directed through the 
?bers. 
Fibers thus produced according to the principles of the 
invention provide a safe and reliable means of photocoagu 
lating tissue With a laser activated optical ?ber Without 
exhibiting the thermal-mechanical breakdown phenomenon 
common to ordinary silica-based ?bers. The ?bers of the 
invention Will provide a surgeon using lasers With a stable 
?ber Whose properties and performance do not change 
throughout a typical laser surgical procedure. The increased 
stability of the optical ?ber of the invention Will therefore 
enable surgeons to perform laser surgery procedures more 
reliably, controllably and safely than When ordinary silica 
?bers are used. 
The physical, chemical, and optical properties of the 
titania-doped silica optical ?bers of the invention are similar 
to those of the silica ?bers except that they exhibit a slightly 
higher index of refraction and, as described above, a much 
loWer, near Zero, linear coef?cient of thermal expansion. The 
similarities alloW them to be used With all the common lasers 
used in surgery. 
The preferred ?bers of the invention can also be provided 
in the same diameters and lengths and use the same optical 
and surgical connectors and ?ttings as those of the silica 
?bers Which, combined With the similar optical properties, 
Will alloW them to be used completely interchangeably With 
all the common commercial surgical lasers noW being used 
With the silica-based ?bers. The laser-optical ?ber-tissue 
response is also identical to that resulting from the silica 
based optical ?ber system, except that the titania-doped 
silica ?ber remains stable throughout the surgical procedure. 
The cost and technical requirements of producing the titania 
doped optical ?bers of the invention are also very similar to 
those of the silica ?bers. All of these similarities to the 
silica-based optical ?bers of the invention a great improve 
ment in the optical ?ber laser surgery technology. 
Having thus described the invention in connection With 
the preferred embodiment thereof, it Will be evident to those 
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skilled in the art that various revisions and modi?cations can 
be made to the preferred embodiment Without departing 
from the spirit and scope of the invention. It is our intention, 
hoWever, that all such revisions and modi?cations as are 
obvious to those skilled in the art Will be included Within the 
scope of the folloWing claims. 
What is claimed is: 
1. A method for laser treatment of tissue comprising the 
steps of: 
a) providing a laser ?ber having a core constructed of 
silica-titania glass, the core terminating in a tip; and 
b) transmitting laser energy through the core to treat 
tissue, Wherein the tip retains its integrity during treat 
ment. 
2. The method of claim 1, further comprising the step of 
contacting tissue With the laser ?ber tip. 
3. The method of claim 1, further comprising the step of 
incising the tissue With the laser energy. 
4. The method of claim 1, Wherein the silica-titania glass 
exhibits a thermal coef?cient of linear expansion of less than 
about 0.5><10_6/°C. in temperatures from about 25° C. to 
about 700° C. 
5. The method of claim 1, Wherein the silica-titania glass 
is substantially colorless. 
6. The method of claim 1, further comprising the steps of: 
a) absorbing laser energy in the core proximate the tip; 
and 
b) contacting tissue With the tip to thereby incise the 
tissue. 
7. The method of claim 6, Wherein the step of absorbing 
laser energy further comprises providing a laser absorbing 
dopant in the core proximate the tip. 
8. The method of claim 7, further comprising the step of 
varying the concentration of the laser absorbing dopant to 
provide a predetermined level of laser energy absorption. 
9. The method of claim 1, Wherein the step of providing 
a laser ?ber further comprises providing a laser ?ber having 
a core consisting essentially of silica-titania glass. 
10. The method of claim 9, Wherein the core comprises a 
concentration of TiO2 of about 7.5 percent by Weight. 
11. A method for laser treatment of tissue comprising the 
steps of: 
a) providing a laser ?ber having a core of silica-titania 
glass exhibiting a thermal coef?cient of linear expan 
sion of less than about 0.5><10_6/°C. in temperatures 
from about 25° C. to about 700° C., the core terminat 
ing in a tip; and 
b) transmitting laser energy through the core; 
c) absorbing laser energy in the core proximate the tip; 
d) contacting tissue With the laser ?ber tip; and 
e) incising the tissue With the laser energy, Wherein the tip 
retains its integrity during treatment. 
12. The method of claim 11, Wherein the silica-titania 
glass is substantially colorless. 
13. The method of claim 11, Wherein the step of providing 
a laser ?ber further comprises providing a laser ?ber having 
a core consisting essentially of silica-titania glass. 
14. The method of claim 13, Wherein the core comprises 
a concentration of TiO2 of about 7.5 percent by Weight. 
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